Qiagen (QGEN) Competitors

BioNTech (NASDAQ:BNTX) and Qiagen (NYSE:QGEN) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

Is BNTX or QGEN more profitable?

Qiagen has a net margin of 4.73% compared to BioNTech's net margin of -15.16%. Qiagen's return on equity of 13.43% beat BioNTech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioNTech	-15.16%	-2.35%	-2.05%
Qiagen	4.73%	13.43%	8.10%

Does the MarketBeat Community prefer BNTX or QGEN?

Qiagen received 115 more outperform votes than BioNTech when rated by MarketBeat users. Likewise, 60.78% of users gave Qiagen an outperform vote while only 44.93% of users gave BioNTech an outperform vote.

Company	Underperform	Outperform
BioNTech	Outperform Votes 133 44.93%	Underperform Votes 163 55.07%
Qiagen	Outperform Votes 248 60.78%	Underperform Votes 160 39.22%

Which has stronger valuation and earnings, BNTX or QGEN?

BioNTech has higher revenue and earnings than Qiagen. BioNTech is trading at a lower price-to-earnings ratio than Qiagen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioNTech	$4.13B	5.78	$1.01B	-$2.10	-47.49
Qiagen	$1.97B	4.79	$341.30M	$0.39	105.82

Do analysts rate BNTX or QGEN?

BioNTech currently has a consensus price target of $137.54, suggesting a potential upside of 37.92%. Qiagen has a consensus price target of $50.88, suggesting a potential upside of 23.28%. Given BioNTech's stronger consensus rating and higher probable upside, equities research analysts clearly believe BioNTech is more favorable than Qiagen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioNTech	0 Sell rating(s)	4 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.79
Qiagen	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60

Does the media favor BNTX or QGEN?

In the previous week, BioNTech had 9 more articles in the media than Qiagen. MarketBeat recorded 21 mentions for BioNTech and 12 mentions for Qiagen. Qiagen's average media sentiment score of 0.77 beat BioNTech's score of 0.39 indicating that Qiagen is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BioNTech	5 Very Positive mention(s)	3 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Qiagen	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility and risk, BNTX or QGEN?

BioNTech has a beta of 0.26, suggesting that its share price is 74% less volatile than the S&P 500. Comparatively, Qiagen has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500.

Do insiders and institutionals hold more shares of BNTX or QGEN?

15.5% of BioNTech shares are held by institutional investors. Comparatively, 70.0% of Qiagen shares are held by institutional investors. 19.2% of BioNTech shares are held by company insiders. Comparatively, 9.0% of Qiagen shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Qiagen beats BioNTech on 10 of the 19 factors compared between the two stocks.